Start the conversation
4/24/15: Shares of AstraZeneca Plc. (NYSE ADR: AZN) slipped more than 3.2% this morning on news sales slipped by 6% in Q1. The company cited new competition from Nexium generics, and of course, the strength of the U.S. dollar. The stronger greenback continues to affect earnings reports of companies that rely on foreign markets for the bulk of their profits. This morning, Xerox Corp. (NYSE: XRX) slipped 4.5% on similar impacts by the dollar.